STANDARD BIOTOOLS INC. (LAB)
Health Care · Nasdaq
Standard BioTools delivers life sciences tools for genomics, proteomics, and cell analysis used by researchers and diagnosticians worldwide.
What STANDARD BIOTOOLS INC. does
Standard BioTools Inc. develops and commercializes life sciences research and diagnostic tools, including genomic sequencing assays (Delta Gene, SNP Type), protein analysis systems (Maxpar reagents), and cell analysis platforms (Access Array). The company generates revenue from both product sales and services, with a significant portion derived from international customers (67% of 2025 revenue). The company manufactures products based on customer demand forecasts and serves the research and diagnostic market segments globally.
Themes: ["genomics / sequencing","proteomics","cell analysis","life sciences research tools","diagnostic assays","Supply chain concentration: certain raw materials and metals used in core assays and reagents are available from limited or sole sources, with no long-term supply agreements in place.","Revenue decline and operational losses: continuing operations generated a net loss of $14.6 million in Q1 2026, with overall revenue declining 49.17% year-over-year, driven by discontinued operations.","Hazardous materials handling: research and manufacturing processes involve controlled use of flammables, toxics, corrosives, and biologics; no separate environmental liability coverage is maintained, creating potential exposure to penalties and operational suspension.","Illumina","Bio-Rad Laboratories"]
Fundamentals
- Price$0.92 as of 2026-07-10 close
- Market cap$360M as of 2026-07-13
- 1-year return-32.0% as of 2026-07-10 close
- P/E4.60 as of 2026-07-13
- Net margin+90.7% as of 2026-07-13
- Gross margin+49.6% as of 2026-07-13
- ROE+17.3% as of 2026-07-13
- Debt / equity0.00 as of 2026-07-13
- Revenue growth (YoY)-49.2% as of 2026-07-13
- Revenue CAGR (3y)-4.5% SEC XBRL
- Beta1.46 as of 2026-07-13
Key risks (from latest filing)
[]
Fundamentals: Finnhub, as of 2026-07-13. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-10.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.